Top U.S. proton pump inhibitors based on revenue 2013
This statistic displays the top ten proton pump inhibitors based on total U.S. revenue in 2013. In that year, Aciphex was among the leading proton pump inhibitors generating a total of 693 million U.S. dollars in revenue in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.
